CLSI EP26-A

User Evaluation of Between-Reagent Lot Variation; Approved Guideline, EP26AE

Clinical and Laboratory Standards Institute, 09/01/2013

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:01/09/2013

Pages:66

File Size:1 file , 2.1 MB

Note:This product is unavailable in Russia, Belarus

This document provides guidance for laboratories on the evaluation of a new reagent lot, including a protocol using patient samples to detect significant changes from the current lot.

More CLSI standard pdf

CLSI MM19-A

Establishing Molecular Testing in Clinical Laboratory Environments; Proposed Guideline, MM19AE

$90.00 $180.00

CLSI M43-A

Methods for Antimicrobial Susceptibility Testing for Human Mycoplasmas; Approved Guideline, M43AE

$90.00 $180.00

CLSI EP23-A (R2018)

Laboratory Quality Control Based on Risk Management; Approved Guideline, EP23AE

$90.00 $180.00

CLSI VET05-R (R2018)

Generation, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE

$90.00 $180.00